Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies
暂无分享,去创建一个
D J Brooks | Richard S. J. Frackowiak | S Osman | R. Frackowiak | C. Bench | D. Brooks | A. Lammertsma | S. Osman | S. Hume | A. Lammertsma | C J Bench | R S Frackowiak | K. Gunn | S P Hume | A A Lammertsma | K Gunn | K. M. Gunn | David J. Brooks
[1] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[2] J. M. Daly,et al. Dopamine Receptors in the Human Brain , 1994 .
[3] Peter Herscovitch,et al. Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission Tomography , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] H. Akaike. A new look at the statistical model identification , 1974 .
[5] T Greitz,et al. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[6] Richard S. J. Frackowiak,et al. Striatal function in normal aging: Implications for Parkinson's disease , 1990, Annals of neurology.
[7] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[8] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[9] U Ruotsalainen,et al. PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.
[10] G. Sedvall,et al. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. , 1988, Archives of general psychiatry.
[11] V J Cunningham,et al. Compartmental Analysis of Diprenorphine Binding to Opiate Receptors in the Rat in vivo and its Comparison with Equilibrium Data in vitro , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] L. Farde,et al. Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] R. Myers,et al. Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomography , 1992, Synapse.
[14] J. Fields,et al. Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol , 1977, Brain Research.
[15] Richard S. J. Frackowiak,et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.
[16] J S Fowler,et al. Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] G. Sedvall,et al. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.
[18] M. Gilardi,et al. Physical performance of the latest generation of commercial positron scanner , 1988 .
[19] V. Cunningham. Non-linear regression techniques in data analysis. , 1985, Medical informatics = Medecine et informatique.
[20] L. Farde,et al. PET analysis of central [11 C]raclopride binding in healthy young adults and schizophrenic patients—reliability and age effects , 1992 .
[21] J. M. Ollinger,et al. Positron Emission Tomography , 2018, Handbook of Small Animal Imaging.
[22] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] G Blomqvist,et al. On the Construction of Functional Maps in Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] D. R. Turton,et al. An automated system based on solid phase extraction and HPLC for the routine determination in plasma of unchanged carbon-11 L-deprenyl Carbon-11 diprenorphine; carbon-11 flumazenil; Carbon-11 raclopride and Carbon-11 Scherring 23390 , 1993 .
[25] R. Frackowiak,et al. Measurement of Cerebral Monoamine Oxidase B Activity Using L-[11C]Deprenyl and Dynamic Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] R S Frackowiak,et al. Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status. , 1993, Brain : a journal of neurology.
[27] R A Robb,et al. A software system for interactive and quantitative visualization of multidimensional biomedical images. , 1991, Australasian physical & engineering sciences in medicine.
[28] K. Leenders,et al. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride. , 1993, Archives of neurology.
[29] S. Stone-Elander,et al. No D2 receptor increase in PET study of schizophrenia. , 1987, Archives of general psychiatry.
[30] C. Halldin,et al. Ligand metabolites in plasma during PET‐studies with the 11C‐labelled dopamine antagonists, raclopride, SCH 23390 and N‐methylspiroperidol , 1992 .
[31] V. Ibáñez,et al. Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: A positron emission tomographic study , 1991, Annals of neurology.
[32] U Ruotsalainen,et al. Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] S O Ogren,et al. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.
[34] P. Seeman,et al. Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride. , 1990, Archives of general psychiatry.